Need professional-grade analysis? Visit stockanalysis.com
$48.60M
N/A
N/A
N/A
Price Chart
Risk-Adjusted Performance
OS Therapies Incorporated (OSTX) Price Performance
OS Therapies Incorporated (OSTX) trades on United States in USD. The company is classified in the Healthcare sector under the Pharmaceutical Preparations industry. The stock currently trades at $1.38, down 10.39% from the previous close.
Over the past year, OSTX has traded between a low of $1.12 and a high of $2.50. The stock has lost 15.3% over this period. It is currently 44.8% below its 52-week high.
OS Therapies Incorporated has a market capitalization of $48.60M.
About OS Therapies Incorporated
OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone dioxide linker technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. OS Therapies Incorporated was incorporated in 2018 and is based in Grasonville, Maryland.
Company Info
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Exchange
- United States
- Currency
- USD
- Country
- United States
Financial Metrics
- Revenue (TTM)
- N/A
- EBITDA
- $-19,444,696
- Profit Margin
- N/A
- EPS (TTM)
- -0.81
- Book Value
- 0.11
Technical Indicators
- 52 Week High
- $2.57
- 52 Week Low
- $1.12
- 50 Day MA
- $1.40
- 200 Day MA
- $1.76
- Beta
- N/A
Valuation
- Trailing P/E
- N/A
- Forward P/E
- -4.15
- Price/Sales
- N/A
- Price/Book
- 12.66
- Enterprise Value
- $47.79M